Table of Contents Author Guidelines Submit a Manuscript
Journal of Biomedicine and Biotechnology
Volume 2010, Article ID 834326, 7 pages
http://dx.doi.org/10.1155/2010/834326
Research Article

Tomatine Adjuvantation of Protective Immunity to a Major Pre-erythrocytic Vaccine Candidate of Malaria is Mediated via T Cell Release of IFN-

1Institute of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds LS2 9JT, UK
2Department of Biology, University of York, York YO10 5YW, UK

Received 1 August 2009; Revised 26 October 2009; Accepted 8 January 2010

Academic Editor: Abhay R. Satoskar

Copyright © 2010 Karen G. Heal and Andrew W. Taylor-Robinson. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. Sheikh, M. Al-Shamisi, and W. J. W. Morrow, “Delivery systems for molecular vaccination,” Current Opinion in Molecular Therapeutics, vol. 2, no. 1, pp. 37–54, 2000. View at Google Scholar · View at Scopus
  2. C. S. Schmidt, W. J. W. Morrow, and N. A. Sheikh, “Smart adjuvants: mechanisms of action,” Expert Review of Vaccines, vol. 6, no. 3, pp. 391–400, 2007. View at Google Scholar
  3. S. Raychaudhuri and W. J. W. Morrow, “Can soluble antigens induce CD8+ cytotoxic T-cell responses? A paradox revisited,” Immunology Today, vol. 14, no. 7, pp. 344–348, 1993. View at Google Scholar · View at Scopus
  4. E. A. Keukens, T. de Vrije, C. van den Boom et al., “Molecular basis of glycoalkaloid induced membrane disruption,” Biochimica et Biophysica Acta, vol. 1240, no. 2, pp. 216–228, 1995. View at Publisher · View at Google Scholar · View at Scopus
  5. E. A. Keukens, T. de Vrije, L. A. Jansen et al., “Glycoalkaloids selectively permeabilize cholesterol containing membranes,” Biochimica et Biophysica Acta, vol. 1279, no. 2, pp. 243–250, 1996. View at Publisher · View at Google Scholar · View at Scopus
  6. N. S. Hyslop and A. W. Morrow, “The influence of aluminium hydroxide content, dose volume and the inclusion of saponin on the efficacy of inactivated foot-and-mouth disease vaccines,” Research in Veterinary Science, vol. 10, no. 2, pp. 109–120, 1969. View at Google Scholar · View at Scopus
  7. C. M. Rick, J. W. Uhlig, and A. D. Jones, “High alpha-tomatine content in ripe fruit of Andean Lycopersicon esculentum var. cerasiforme: developmental and genetic aspects,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 26, pp. 12877–12881, 1994. View at Google Scholar
  8. P. Rajananthanan, G. S. Attard, N. A. Sheikh, and W. J. W. Morrow, “Evaluation of novel aggregate structures as adjuvants: composition, toxicity studies and humoral responses,” Vaccine, vol. 17, no. 7-8, pp. 715–730, 1999. View at Publisher · View at Google Scholar · View at Scopus
  9. J. G. Breman, “Eradicating malaria,” Science Progress, vol. 92, no. 1, pp. 1–38, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. A. W. Taylor-Robinson, “Exoerythrocytic malaria vaccine development: understanding host-parasite immunobiology underscores strategic success,” Expert Review of Vaccines, vol. 1, no. 3, pp. 317–340, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. A. W. Taylor-Robinson and E. C. Smith, “A role for cytokines in potentiation of malaria vaccines through immunological modulation of blood stage infection,” Immunological Reviews, vol. 171, pp. 105–123, 1999. View at Publisher · View at Google Scholar · View at Scopus
  12. A. W. Taylor-Robinson, “Immunity to liver stage malaria: considerations for vaccine design,” Immunologic Research, vol. 27, no. 1, pp. 53–69, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. P. Romero, J. L. Maryanski, G. Corradin, R. S. Nussenzweig, V. Nussenzweig, and F. Zavala, “Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria,” Nature, vol. 341, no. 6240, pp. 323–326, 1989. View at Publisher · View at Google Scholar · View at Scopus
  14. W. R. Weiss, J. A. Berzofsky, R. A. Houghten, M. Sedegah, M. Hollindale, and S. L. Hoffman, “A T cell clone directed at the circumsporozoite protein which protects mice against both Plasmodium yoelii and Plasmodium berghei,” Journal of Immunology, vol. 149, no. 6, pp. 2103–2109, 1992. View at Google Scholar · View at Scopus
  15. J. A. Stoute, M. Slaoui, D. G. Heppner et al., “A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria,” New England Journal of Medicine, vol. 336, no. 2, pp. 86–91, 1997. View at Publisher · View at Google Scholar · View at Scopus
  16. P. Sun, R. Schwenk, K. White et al., “Protective immunity induced with malaria vaccine, RTS,S, is linked to Plasmodium falciparum circumsporozoite protein-specific CD4+ and CD8+ T cells producing IFN-?,” Journal of Immunology, vol. 171, no. 12, pp. 6961–6967, 2003. View at Google Scholar · View at Scopus
  17. P. Rajananthanan, G. S. Attard, N. A. Sheikh, and W. J. W. Morrow, “Novel aggregate structure adjuvants modulate lymphocyte proliferation and Th1 and Th2 cytokine profiles in ovalbumin immunized mice,” Vaccine, vol. 18, no. 1-2, pp. 140–152, 1999. View at Publisher · View at Google Scholar · View at Scopus
  18. A. W. Taylor-Robinson and R. S. Phillips, “Functional characterization of protective CD4+ T-cell clones reactive to the murine malaria parasite Plasmodium chabaudi,” Immunology, vol. 77, no. 1, pp. 99–105, 1992. View at Google Scholar · View at Scopus
  19. K. G. Heal, H. R. Hill, P. G. Stockley, M. R. Hollingdale, and A. W. Taylor-Robinson, “Expression and immunogenicity of a liver stage malaria epitope presented as a foreign peptide on the surface of RNA-free MS2 bacteriophage capsids,” Vaccine, vol. 18, no. 3-4, pp. 251–258, 1999. View at Publisher · View at Google Scholar · View at Scopus
  20. K. G. Heal, N. A. Sheikh, M. R. Hollingdale, W. J. W. Morrow, and A. W. Taylor-Robinson, “Potentiation by a novel alkaloid glycoside adjuvant of a protective cytotoxic T cell immune response specific for a preerythrocytic malaria vaccine candidate antigen,” Vaccine, vol. 19, no. 30, pp. 4153–4161, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. W. L. Brown, R. A. Mastico, M. Wu et al., “RNA bacteriophage capsid-mediated drug delivery and epitope presentation,” Intervirology, vol. 45, no. 4–6, pp. 371–380, 2002. View at Publisher · View at Google Scholar · View at Scopus
  22. A. W. Taylor-Robinson and R. S. Phillips, “Th1 and Th2 CD4+ T cell clones specific for Plasmodium chabaudi but not for an unrelated antigen protect against blood stage P. chabaudi infection,” European Journal of Immunology, vol. 24, no. 1, pp. 158–164, 1994. View at Google Scholar
  23. L. Schofield, J. Villaquiran, A. Ferreira, H. Schellekens, R. Nussenzweig, and V. Nussenzweig, “γ-interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites,” Nature, vol. 330, no. 6149, pp. 664–666, 1987. View at Google Scholar · View at Scopus
  24. W. R. Weiss, M. Sedegah, R. L. Beaudoin, L. H. Miller, and M. F. Good, “CD8+ T cells (cytotoxic/suppressors) are required for protection in mice immunized with malaria sporozoites,” Proceedings of the National Academy of Sciences of the United States of America, vol. 85, no. 2, pp. 573–576, 1988. View at Google Scholar · View at Scopus
  25. S. L. Hoffman, D. Isenbarger, G. W. Long et al., “Sporozoite vaccine induces genetically restricted T cell elimination of malaria from hepatocytes,” Science, vol. 244, no. 4908, pp. 1078–1081, 1989. View at Google Scholar · View at Scopus
  26. O. Jobe, J. Lumsden, A.-K. Mueller et al., “Genetically attenuated Plasmodium berghei liver stages induce sterile protracted protection that is mediated by major histocompatibility complex class I-dependent interferon-?-producing CD8+ T cells,” Journal of Infectious Diseases, vol. 196, no. 4, pp. 599–607, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Ferreira, L. Schofield, V. Enea et al., “Inhibition of development of exoerythrocytic froms of malaria parasites by ?-interferon,” Science, vol. 232, no. 4752, pp. 881–884, 1986. View at Google Scholar · View at Scopus
  28. S. Mellouk, R. K. Maheshwari, A. Rhodes-Feuillette et al., “Inhibitory activity of interferons and interleukin 1 on the development of Plasmodium falciparum in human hepatocyte cultures,” Journal of Immunology, vol. 139, no. 12, pp. 4192–4195, 1987. View at Google Scholar · View at Scopus
  29. M. C. Seguin, F. W. Klotz, I. Schneider et al., “Induction of nitric oxide synthase protects against malaria in mice exposed to irradiated Plasmodium berghei infected mosquitoes: involvement of interferon ? and CD8+ T cells,” Journal of Experimental Medicine, vol. 180, no. 1, pp. 353–358, 1994. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Sedegah, F. Finkelman, and S. L. Hoffman, “Interleukin 12 induction of interferon γ-dependent protection against malaria,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 22, pp. 10700–10702, 1994. View at Publisher · View at Google Scholar · View at Scopus
  31. R. K. Maheshwari, C. W. Czarniecki, G. P. Dutta, S. K. Puri, B. N. Dhawan, and M. Friedman, “Recombinant human gamma interferon inhibits simian malaria,” Infection and Immunity, vol. 53, no. 3, pp. 628–630, 1986. View at Google Scholar · View at Scopus
  32. S. L. Hoffman, J. M. Crutcher, S. K. Puri et al., “Sterile protection of monkeys against malaria after administration of interleukin-12,” Nature Medicine, vol. 3, no. 1, pp. 80–83, 1997. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Mellouk, S. J. Green, C. A. Nacy, and S. L. Hoffman, “IFN-γ inhibits development of Plasmodium berghei exoerythrocytic stages in hepatocytes by an L-arginine-dependent effector mechanism,” Journal of Immunology, vol. 146, no. 11, pp. 3971–3976, 1991. View at Google Scholar · View at Scopus
  34. S. Mellouk, S. L. Hoffman, Z. Z. Liu, P. de la Vega, T. R. Billiar, and A. K. Nussler, “Nitric oxide-mediated antiplasmodial activity in human and murine hepatocytes induced by gamma interferon and the parasite itself: enhancement by exogenous tetrahydrobiopterin,” Infection and Immunity, vol. 62, no. 9, pp. 4043–4046, 1994. View at Google Scholar · View at Scopus
  35. J. Renggli, M. Hahne, H. Matile, B. Betschart, J. Tschopp, and G. Corradin, “Elimination of P. berghei liver stages is independent of Fas (CD95/Apo-I) or perforin-mediated cytotoxicity,” Parasite Immunology, vol. 19, no. 3, pp. 145–148, 1997. View at Google Scholar · View at Scopus
  36. D. L. Doolan and N. Martinez-Alier, “Immune response to pre-erythrocytic stages of malaria parasites,” Current Molecular Medicine, vol. 6, no. 2, pp. 169–185, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. U. Krzych and J. Schwenk, “The dissection of CD8 T cells during liver-stage infection,” Current Topics in Microbiology and Immunology, vol. 297, no. 1, pp. 1–24, 2005. View at Google Scholar · View at Scopus
  38. A. W. Taylor-Robinson and W. J. W. Morrow, “Tomatine as an adjuvant in malaria vaccine development,” Drugs of the Future, vol. 27, no. 4, pp. 391–402, 2002. View at Google Scholar
  39. W. J. W. Morrow, Y.-W. Yang, and N. A. Sheikh, “Immunobiology of the Tomatine adjuvant,” Vaccine, vol. 22, no. 19, pp. 2380–2384, 2004. View at Publisher · View at Google Scholar · View at Scopus
  40. D. L. Doolan and S. L. Hoffman, “The complexity of protective immunity against liver-stage malaria,” Journal of Immunology, vol. 165, no. 3, pp. 1453–1462, 2000. View at Google Scholar · View at Scopus